Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This antioxidant combination therapy, consisting of ascorbate (Vitamin C), vitamin E, zinc, and selenium, is being investigated by researchers at Cairo University. The regimen is specifically designed to address oxidative stress in women with endometriosis who are undergoing assisted reproductive techniques, such as intracytoplasmic sperm injection (ICSI). By supplementing with high doses of these antioxidants (1000mg ascorbate and 400 IU vitamin E, alongside zinc and selenium), the treatment aims to reduce elevated levels of reactive oxygen species (ROS) in the plasma and follicular fluid. High ROS levels are a known factor in the pathogenesis of endometriosis and are associated with negative outcomes in in vitro fertilization (IVF). The primary therapeutic goal is to improve pregnancy outcomes by neutralizing free radicals and supporting the body's endogenous antioxidant enzyme systems.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ascorbate + vitamin E + zinc + selenium.